Gilead Sciences pays $3.95 billion upfront makes $1.1billion equity investment as part of deal with Galapagos httpswww.firstwordpharma.comnode1652817Â $GLPG $GILD

Gilead Sciences pays $3.95 billion upfront, makes $1.1-billion equity investment as part of deal with Galapagos https://www.firstwordpharma.com/node/1652817  $GLPG $GILD

17:17 EDT 14 Jul 2019 | FirstWord Pharma

Gilead Sciences pays $3.95 billion upfront, makes $1.1-billion equity investment as part of deal with Galapagos https://www.firstwordpharma.com/node/1652817  $GLPG $GILD

More From BioPortfolio on "Gilead Sciences pays $3.95 billion upfront, makes $1.1-billion equity investment as part of deal with Galapagos https://www.firstwordpharma.com/node/1652817  $GLPG $GILD"